U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C2H3ClO
Molecular Weight 78.498
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CHLOROACETALDEHYDE

SMILES

ClCC=O

InChI

InChIKey=QSKPIOLLBIHNAC-UHFFFAOYSA-N
InChI=1S/C2H3ClO/c3-1-2-4/h2H,1H2

HIDE SMILES / InChI

Molecular Formula C2H3ClO
Molecular Weight 78.498
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Ifosfamide toxicity in cultured proximal renal tubule cells.
2007-03
The chloromethylketone protease inhibitor AAPF(CMK) also targets ATP-dependent helicases and SAP-domain proteins.
2007-02-15
Selective thiourea optical probe based on thiourea-induced removal of chloroacetyl group from chloroacetylamine.
2006-12
Thiol-mediated anchoring of ligands to self-assembled monolayers for studies of biospecific interactions.
2006-11-21
Ifosfamide metabolites CAA, 4-OH-Ifo and Ifo-mustard reduce apical phosphate transport by changing NaPi-IIa in OK cells.
2006-11
Synthesis of 2-alkenyl-3-(alkoxycarbonyl)furans based on Feist-Benary cyclocondensation of (2,4-dioxobutylidene)phosphoranes with alpha-haloketones and alpha-chloracetaldehyde.
2006-10-13
Selective alteration of the rate-limiting step in cytosolic aldehyde dehydrogenase through random mutagenesis.
2006-08-08
Ifosfamide-induced nephrotoxicity: mechanism and prevention.
2006-08-01
Efficient method for the deprotection of tert-butyldimethylsilyl ethers with TiCl4-Lewis base complexes: application to the synthesis of 1beta-methylcarbapenems.
2006-07-07
Enantioselective metabolism of ifosfamide by the kidney.
2006-06
[Increased urinary excretion of the neurotoxic side-chain metabolites of ifosphamide in children with polymorphism of the glutathione S-transferases genes].
2006-05-25
Directed evolution of an industrial biocatalyst: 2-deoxy-D-ribose 5-phosphate aldolase.
2006-05
Peptides containing acylated C-terminal gem diamines: novel irreversible inactivators of the cysteine and serine proteinases.
2006-05
Ifosfamide: pharmacokinetic properties for central nervous system metastasis prevention.
2006-05
Systematic synthesis of bisubstrate-type inhibitors of N-acetylglucosaminyltransferases.
2006-04-24
Insights into the hydrogen-abstraction reactions of diol dehydratase: relevance to the catalytic mechanism and suicide inactivation.
2006-03-15
A new protein superfamily includes two novel 3-methyladenine DNA glycosylases from Bacillus cereus, AlkC and AlkD.
2006-03
Chloroacetaldehyde: mode of antitumor action of the ifosfamide metabolite.
2006-02
Hydroxyl-terminated dendritic oligomers from bile acids: synthesis and properties.
2006-01-20
Chloroacetaldehyde- and acrolein-induced death of human proximal tubule cells.
2006-01
Chloroacetaldehyde as a sulfhydryl reagent: the role of critical thiol groups in ifosfamide nephropathy.
2006
Application of biological activated carbon anaerobic reactor for treatment of hazardous chemicals.
2006
Sequence-specific p53 gene damage by chloroacetaldehyde and its repair kinetics in Escherichia coli.
2006
Site specific synthesis and polymerase bypass of oligonucleotides containing a 6-hydroxy-3,5,6,7-tetrahydro-9H-imidazo[1,2-a]purin-9-one base, an intermediate in the formation of 1,N2-etheno-2'-deoxyguanosine.
2005-11
Disturbed Ca2+-signaling by chloroacetaldehyde: a possible cause for chronic ifosfamide nephrotoxicity.
2005-11
Mechanisms of solvolyses of acid chlorides and chloroformates. Chloroacetyl and phenylacetyl chloride as similarity models.
2005-10-28
ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal.
2005-10-04
AlkB reverses etheno DNA lesions caused by lipid oxidation in vitro and in vivo.
2005-10
Dynamic analysis of metabolic effects of chloroacetaldehyde and cytochalasin B on tumor cells using bioelectronic sensor chips.
2005-10
Ifosfamide-induced encephalopathy with or without using methylene blue.
2005-09-22
Enantioselective metabolism and cytotoxicity of R-ifosfamide and S-ifosfamide by tumor cell-expressed cytochromes P450.
2005-09
Synthesis, characterisation and theoretical calculations of 2,6-diaminopurine etheno derivatives.
2005-08-21
Palladium-catalyzed regioselective arylation of imidazo[1,2-b][1,2,4]triazine: synthesis of an alpha 2/3-selective GABA agonist.
2005-07-22
Cytochrome P450 3A and 2B6 in the developing kidney: implications for ifosfamide nephrotoxicity.
2005-07
Contribution of CYP3A5 to hepatic and renal ifosfamide N-dechloroethylation.
2005-07
Differential effects of Mg2+ ions on the individual kinetic steps of human cytosolic and mitochondrial aldehyde dehydrogenases.
2005-06-07
A tubule cell model for ifosfamide nephrotoxicity.
2005-06
[Optimization of transfection properties of DNA-lysine dendrimer complexes].
2005-05-14
Exocyclic DNA lesions stimulate DNA cleavage mediated by human topoisomerase II alpha in vitro and in cultured cells.
2005-03-15
Matrix isolation and theoretical study of the photochemical reaction of CrCl2O2 with chloroethenes.
2005-02-10
One-step synthesis of labeled sugar nucleotides for protein O-GlcNAc modification studies by chemical function analysis of an archaeal protein.
2005-01-26
Polymorphisms of DNA repair gene XPD and DNA damage of workers exposed to vinylchloride monomer.
2005
Mismatch dependent uracil/thymine-DNA glycosylases excise exocyclic hydroxyethano and hydroxypropano cytosine adducts.
2005
DNA damage and mutations produced by chloroacetaldehyde in a CpG-methylated target gene.
2004-12-21
Role of mismatch-specific uracil-DNA glycosylase in repair of 3,N4-ethenocytosine in vivo.
2004-12-02
Renal ontogeny of ifosfamide nephrotoxicity.
2004-12
Analysis of drug action on tumor cell metabolism using electronic sensor chips.
2004-12
Degradation pathway of 2-chloroethanol in Pseudomonas stutzeri strain JJ under denitrifying conditions.
2004-12
Release of beta-nicotinamide adenine dinucleotide upon stimulation of postganglionic nerve terminals in blood vessels and urinary bladder.
2004-11-19
Suicide inactivation of dioldehydratase by glycolaldehyde and chloroacetaldehyde: an examination of the reaction mechanism.
2004-10-06
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:27:51 GMT 2025
Edited
by admin
on Mon Mar 31 19:27:51 GMT 2025
Record UNII
CF069F5D9C
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CHLOROACETALDEHYDE [HSDB]
Preferred Name English
CHLOROACETALDEHYDE
HSDB   MI  
Systematic Name English
CHLOROACETALDEHYDE [MI]
Common Name English
Code System Code Type Description
CHEBI
27871
Created by admin on Mon Mar 31 19:27:51 GMT 2025 , Edited by admin on Mon Mar 31 19:27:51 GMT 2025
PRIMARY
MERCK INDEX
m3379
Created by admin on Mon Mar 31 19:27:51 GMT 2025 , Edited by admin on Mon Mar 31 19:27:51 GMT 2025
PRIMARY Merck Index
MESH
C004656
Created by admin on Mon Mar 31 19:27:51 GMT 2025 , Edited by admin on Mon Mar 31 19:27:51 GMT 2025
PRIMARY
FDA UNII
CF069F5D9C
Created by admin on Mon Mar 31 19:27:51 GMT 2025 , Edited by admin on Mon Mar 31 19:27:51 GMT 2025
PRIMARY
WIKIPEDIA
CHLOROACETALDEHYDE
Created by admin on Mon Mar 31 19:27:51 GMT 2025 , Edited by admin on Mon Mar 31 19:27:51 GMT 2025
PRIMARY
ECHA (EC/EINECS)
203-472-8
Created by admin on Mon Mar 31 19:27:51 GMT 2025 , Edited by admin on Mon Mar 31 19:27:51 GMT 2025
PRIMARY
CAS
107-20-0
Created by admin on Mon Mar 31 19:27:51 GMT 2025 , Edited by admin on Mon Mar 31 19:27:51 GMT 2025
PRIMARY
PUBCHEM
33
Created by admin on Mon Mar 31 19:27:51 GMT 2025 , Edited by admin on Mon Mar 31 19:27:51 GMT 2025
PRIMARY
EPA CompTox
DTXSID4020292
Created by admin on Mon Mar 31 19:27:51 GMT 2025 , Edited by admin on Mon Mar 31 19:27:51 GMT 2025
PRIMARY
HSDB
2521
Created by admin on Mon Mar 31 19:27:51 GMT 2025 , Edited by admin on Mon Mar 31 19:27:51 GMT 2025
PRIMARY